Journal of Applied Laboratory Medicine

The Journal of Applied Laboratory Medicine is the applied-laboratory title of the Association for Diagnostics & Laboratory Medicine, published online with Oxford University Press since 2020.应用检验医学杂志是诊断与检验医学协会的应用检验刊物，2020 年起由牛津大学出版社在线出版。

Its 2025 impact factor is 2.3 and the five-year figure is 2.2, with a citation indicator of 0.80.2025 年影响因子 2.3，五年影响因子 2.2，期刊引文指标 0.80。

The journal comes out six times a year, so volume 10 covers 2025 and volume 11 covers 2026.刊物每年出版六期，第 10 卷对应 2025 年，第 11 卷对应 2026 年。

It became fully open access with volume 11 in January 2026, and the whole archive is now free to read.2026 年 1 月第 11 卷起转为完全开放获取，全部存档现在都免费开放。

Research papers carry a charge of 3,100 dollars, commentary carries none, and members of the association pay half.研究论文收取 3100 美元，评论类不收费，协会会员按半价支付。

Scope

• Laboratory methods and the practice of laboratory medicine are the first subjects the journal names.检验方法与检验医学实践是刊物列在最前面的题目。

• Evidence-based laboratory medicine follows, including studies that measure how a test changes clinical outcomes.接着是基于证据的检验医学，包括衡量某项检测如何改变临床结局的研究。

• Clinical chemistry, toxicology and therapeutic drug monitoring all sit inside the scope.临床化学，毒理学与治疗药物监测都在范围之内。

• Microbiology is listed with virology and mycology spelled out.微生物学单独列出，病毒学与真菌学也写明。

• Hematology, coagulation and transfusion medicine are covered as separate areas.血液学，凝血与输血医学各占一个领域。

• Immunology, molecular diagnostics and allergy testing are open to submission.免疫学，分子诊断与过敏检测都接收投稿。

• Informatics, machine learning and artificial intelligence have their own line in the subject list.信息学，机器学习与人工智能在学科清单里单独成条。

• Laboratory management, quality assurance and quality control belong here as well.实验室管理，质量保证与质量控制同样归入本刊。

• Education and training in laboratory medicine, and the economics of testing, are accepted too.检验医学的教育与培训，以及检测经济学，也在接收之列。

• Tissue pathology is the one area the journal excludes by name.组织病理学是刊物点名排除的唯一领域。

• Research articles run to 3,500 words, with a structured abstract of 250 words and at most 40 references.研究论文限 3500 词，附 250 词结构式摘要，参考文献最多 40 条。

• Reviews may reach 5,000 words, 100 references and six tables or figures.综述可达 5000 词，100 条参考文献与 6 个表或图。

• Mini-reviews stop at 3,500 words and four display items.小型综述以 3500 词与 4 个图表为限。

• Focused reports are short research papers capped at 1,500 words.聚焦报告是短篇研究，上限 1500 词。

• Case studies, opinions and point-counterpoint pieces take 1,500 words or fewer.病例研究，观点与正反辩论稿不超过 1500 词。

• Letters and replies are limited to 750 words, five references and one figure.读者来信与答复限 750 词，5 条参考文献与 1 幅图。

• Laboratory Reflections pieces run to 750 words and cover milestones, professional insights and technical tips.实验室随笔类文章限 750 词，分为里程碑，职业心得与技术提示三支。

• Structured abstracts use background, methods, results and conclusions, while reviews use background, content and summary.结构式摘要分背景，方法，结果与结论四段，综述则分背景，内容与总结三段。

• An impact statement of at most 100 words follows the abstract on research papers and reviews.研究论文与综述要在摘要之后附一段不超过 100 词的影响说明。

• Three to five keywords accompany each paper, and the word limit counts the body only.每篇附 3 至 5 个关键词，字数上限只算正文。

• Published papers are sorted into subject categories, among them molecular diagnostics and genetics, point-of-care testing, informatics and statistics.发表的文章按学科归类，分子诊断与遗传学，即时检验，信息学与统计学都在其中。

• A reported study has to be detailed enough for another laboratory to repeat the work.刊出的研究必须写到另一家实验室能照着复现的程度。

• Analyte concentrations are given first in the customary mass unit, with the SI value in brackets behind it.被测物浓度先按惯用的质量单位书写，括号里附国际单位制数值。

• Policy and regulatory questions that shape laboratory practice get a forum here beside the research papers.影响检验实践的政策与监管问题，与研究报告一样在刊内有讨论的版面。

History

• The association, then the American Association for Clinical Chemistry, started the journal in 2016.协会当时名为美国临床化学协会，于 2016 年创办本刊。

• Volume 1 carried the 2016 date, and the new title was meant to sit beside Clinical Chemistry rather than replace it.第 1 卷标注 2016 年，新刊的定位是与《临床化学》并列，而不是取代它。

• The aim was translational work, covering assays, test utilisation, quality and the effect of results on care.办刊目标是转化研究，涵盖检测方法，项目利用，质量以及结果对诊疗的影响。

• Oxford University Press took over publication in 2020, and the National Library of Medicine records Oxford as the imprint from that year.牛津大学出版社 2020 年接手出版，美国国家医学图书馆从这一年起把牛津记为出版地。

• The library began full indexing with volume 3 in July 2018, and earlier papers were cited selectively.该馆从 2018 年 7 月的第 3 卷开始完整收录，更早的论文只选择性引用。

• For most of its life the journal was hybrid, and the gold open access share still stood at 25.37 percent in the 2025 window.刊物大部分时间走混合模式，2025 年统计窗口内的金色开放获取比例仍为 25.37。

• The switch to full open access came with volume 11 in January 2026, and older content was opened at the same time.完全开放获取随 2026 年 1 月的第 11 卷落地，旧内容同时开放。

• The 2023 impact factor was 1.8, and 2024 brought 1.9.2023 年影响因子为 1.8，2024 年升到 1.9。

• The 2025 figure of 2.3 is the highest the title has recorded.2025 年的 2.3 是该刊迄今最高值。

• Clarivate indexes it in ESCI rather than SCIE, under medical laboratory technology, where it ranks 14th of 33.科睿唯安把它收录在 ESCI 而非 SCIE，归入医学检验技术，在 33 种刊中排第 14。

• The 2025 window holds 102 articles and 1,892 citations behind them.2025 年窗口内有 102 篇文章，背后是 1892 次被引。

• The article influence score is 0.642, which is Q2 at 14th of 31.论文影响分值 0.642，在 31 种刊中排第 14，属 Q2。

• The journal is online only, so there is no print run and no separate print subscription.刊物只出在线版，没有纸本印次，也没有单独的纸本订阅。

Editors

• Ian S. Young of Queen's University Belfast is editor-in-chief.主编是贝尔法斯特女王大学的 Ian S. Young。

• He is also a consultant chemical pathologist in Belfast and chief scientific adviser to the Department of Health in Northern Ireland.他同时是贝尔法斯特的化学病理顾问，并担任北爱尔兰卫生部首席科学顾问。

• Allison Chambliss of UCLA is deputy editor and directs laboratory stewardship at UCLA Health.副主编 Allison Chambliss 来自加州大学洛杉矶分校，主管该校医疗系统的检验项目管理工作。

• David Alter of Emory, Robert Benirschke of Endeavor Health and Larry Broussard of Louisiana State University are associate editors.副编辑包括埃默里大学的 David Alter，Endeavor Health 的 Robert Benirschke 与路易斯安那州立大学的 Larry Broussard。

• Sean Campbell in Toronto, Dennis Dietzen at Phoenix Children's and Anna Merrill at Iowa hold the same rank.多伦多的 Sean Campbell，凤凰城儿童医院的 Dennis Dietzen 与艾奥瓦大学的 Anna Merrill 同为副编辑。

• Deborah French of UCSF serves as reviews editor, and Nicholas Larkey of Virginia runs podcasts and social media.加州大学旧金山分校的 Deborah French 任综述编辑，弗吉尼亚大学的 Nicholas Larkey 负责播客与社交媒体。

• The editor-in-chief and the deputy read every submission before an associate editor takes charge of it.每篇投稿先由主编与副主编过目，之后才交到副编辑手里。

• Some papers are declined at that first screen without going to outside referees.一部分稿件在初筛阶段就被退掉，不送外审。

• Papers that go out are reviewed single-blind, so referees know the authors and the authors do not know the referees.送审的稿件采用单盲评审，评审人知道作者是谁，作者不知道评审人。

• An associate editor picks referees from a database, from author suggestions or from personal knowledge.副编辑从专家库，作者推荐或自己熟悉的人里挑选评审人。

• Authors are told to expect a decision in about four weeks.刊物告知作者，决定大约在四周内作出。

• Manuscripts go through ScholarOne, and the editorial office answers queries by email.稿件经 ScholarOne 系统提交，编辑部用电子邮件答复问询。

• Every author completes a conflict-of-interest form, even when there is nothing to declare.每位作者都要填写利益冲突表，即使没有需要申报的内容。